A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”

Tear stability is decreased in <i>Muc5ac</i>-deficient mice (KO) compared to wild-type mice (WT). by Anne M. Floyd (293362)

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)

IL–1β levels and IL–18 expression are markedly decreased in the MyD88^-/- and TLR2^-/- mice. by Deysi V. T. Wong (803817)

Rhox5 decreases UNC5C expression. by Mayumi Sugimoto (151133)

MVEC viability is decreased over time in PEG-based hydrogels. by Rebecca A. Scott (488956)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

HPV16 PsV infection decreases following SLPI treatment or anti-annexin A2 antibody inhibition of A2t. by Andrew W. Woodham (140650)

Decreased STAT3 and increased AMPK protein levels in NLRP3^−/− hearts. by Coert J. Zuurbier (313731)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

Purmorphamine decreases FSK-directed cAMP production in a cilium-independent manner. by Lan Ho Wei (5688020)

Heterozygous TIN2-R282H mutation decreases the frequency of telomere extension by telomerase. by Amanda K. Frank (778017)

NCM treatment decreases hepatic CoQ₁₀, but increases total cholesterol and cholesterol ester levels, which is associated with significant decreases in the expressions of... by Ryan J. Mailloux (50825)

Subjects: “…mitochondrial ATP synthase subunit ATP 5A…”

<i>Fgfr2^+/S252W</i> mice had shortened bone length and decreased bone mass compared with wild-type mice. by Peng Chen (6514)

“…<p>(A–F) X-ray analyses of femora, tibia and lumbar vertebrae from WT and MT mice at P5 (A, B), P10 (C, D) and P28 (E, F) revealed shorter bone length and lower bone density in mutant mice. …”

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Anandamide decreases exploratory behavior in the large open field. by Adriaan W. Bruijnzeel (2605954)

Metformin decreases ATP levels in medium containing low glucose (2.5 mM). by Yongxian Zhuang (634693)

Recovery of decreased Hb level after DCV/ASV treatment Mean values and SDs of the Hb levels at each time point are indicated. by Nobuyuki Matsumoto (239090)

Subjects: